The present study was aimed at evaluating the antibacterial activity of mulinane and azorellane diterpenes isolated from the Andean plants Azorella compacta and A. trifoliolata and semisynthetic derivatives against reference and multidrug-resistant strains. The results revealed that the semisynthetic compound 7-acetoxy-mulin-9,12-diene (5) exhibited antibacterial activity against reference and multidrug-resistant strains of Staphylococcus aureus and moderate antimycobacterial activity against Mycobacterium smegmatis ATCC 14468.
Andean plants belonging to the tribe Mulinae (genera Azorella, Laretia and Mulinum) are recognized as an important source of diterpenoids. About 30 new or rare diterpenoids have been characterized from the tribe Mulinae, which have unique structural features so far unreported from natural and synthetic sources. These compounds possess mulinane, azorellane, yaretane and madreporane skeleta and have been so far only described in members of this tribe [1] [2] [3] . These metabolites possess various biological activities such as antibacterial, antiviral, antiprotozoal, and antituberculosis, as well as spermicidal, cytotoxic, antihyperglycemic, anti-inflammatory and analgesic effects [2, 4, 5, 6] . However, little information is available about the activity of these compounds against multidrug-resistant bacterial pathogens. The increasing prevalence of multiantibiotic-resistant S. aureus and multi/extensively drug-resistant Mycobacterium tuberculosis is a major global health problem [7, 8] . As a part of our ongoing research on diterpenes of species of the genus Azorella, we report herein the in vitro antibacterial properties of diterpenes with mulinane and azorellane skeleta against reference and multidrugresistant Gram-negative and Gram-positive strains. The natural diterpenes and semisynthetic derivatives were also evaluated for in vitro antimycobacterial activity against the fast-growing saprophytic bacteria Mycobacterium smegmatis. In addition, this is the first time that the semisynthetic compound 6 is reported in the chemical literature ( Figure 1 ).
The antibacterial activity of the Azorella diterpenes against Gram-positive and Gram-negative bacteria was evaluated using the disk diffusion method. Only the semisynthetic compound 5 showed activity against an ATCC strain of Staphylococcus aureus and a clinical multiresistant isolate of this bacterium, with inhibition zones of 15 and 13 mm, respectively (70 µg/disk). All compounds lacked activity against the Gram-negative bacteria Klebsiella ozaenae and Acinetobacter sp. Recent studies have shown that organic extracts of Azorella trifurcata and essential oils of A. cryptantha exhibit activity against methicillin-resistant S. aureus [9, 10] . Wachter et al. [11] showed that diterpenoid acids of A. compacta were active against methicillin-resistant and -sensitive S. aureus. Interestingly, recently Bórquez et al. [12] showed that the semisynthetic 5 can also be isolated from a plant source.
The anti-Mycobacterium tuberculosis activity of mulinane and azorellane diterpenes has been reported [2] . Using the model organism M. smegmatis, we have confirmed the antimycobacterial activity of compound 5. This semisynthetic derivative exhibited moderate antimycobacterial activity (MIC: 43.8 µg/mL). However, the other compounds did not show significant inhibitory activity against this mycobacterium. M. smegmatis has been used as a model system for the study of different aspects of the biology of pathogenic mycobacteria and as a surrogate for the evaluation of new antituberculosis agents [13] . This species presents a susceptibility profile to antituberculosis compounds similar to that of M. tuberculosis [14] and its growth inhibition is predictive of antituberculosis activity [13] . The activity of 5 is promising when compared with previously reported MICs of various antibiotics (such as cephalothin, D-cycloserine, erythromycin A) against M. smegmatis [15] , validating further work to evaluate the effects of its structural modification.
Combined with the earlier reported antituberculosis activity of mulinane diterpenes against M. tuberculosis, the present data demonstrate that mulinane diterpenoids possess not only promising activity against mycobacteria, but potentially also for other clinically relevant Gram-positive infections. (ACom3 and ATRI10, respectively) .
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Extraction and isolation:
The aerial parts of A. compacta and A. trifoliolata were dried and milled separately (2000 and 785 g, respectively). The material was extracted 3 times with an organic solvent mixture (n-hexane/EtOAc/dichloromethane), yielding a residue of 226.5 g and 27.4 g for A. compacta and A. trifoliolata, respectively. Chromatographic fractionation of extracts from A. compacta and A. trifoliolata was performed as previously described and yielded 3 known compounds, mulinic acid (1) (15 mg) [1] , azorellanol (2) (15 mg) [3] and 13-α-hydroxyazorellane (3) (7 mg) [2] . Minor structural modifications of the natural compounds yielded two derivatives: 7-deacetylazorellanol (4) [2] and 7acetoxy-mulin-9,12-diene (5) [2] . Mulinic acid methyl ester (6) , was prepared by methylation of 1. Compound 1 (12 mg, Et 2 O) was treated with an ethereal solution of CH 2 N 2 with constant agitation for 12 h at room temperature. Solvent evaporation yielded 6. The compounds were identified by 1 (resistant to cephazolin, cephalotin, cefuroxime, cefepime, chloramphenicol, ceftriaxone, ceftazidime, clavulanic acid). The antibacterial activities of the compounds were determined using the disk-diffusion and broth macrodilution methods according to CLSI guidelines [16] . A penicillin/streptomycin solution was used as positive control and DMSO as negative control. All the assays were carried out in triplicate.
